What is myocardial fibrosis?

myocardial fibrosis is a condition that involves worsening of the muscle cells of the heart called myocytes. It belongs to the class of diseases collectively known as fibrosis, which refers to the tissue of tissue. It is a condition that not only affects the heart, with an example of myocardial fibrosis, but also other organs such as lungs and liver. Myocardial fibrosis is also referred to as a more general term of heart fibrosis.

myocytes that come from the original cells called myoblasts are helpful in checking the heart rate of electrical impulses. Each myocyte cell has a collection of cylindrical fibers called myofibrils. These are cellular units that allow the heart to close. Normally myocytes form cell lines in the heart.

In myocardial fibrosis, myocytes are replaced by tissue that is unable to close. This occurs when fibroblasts that produce collagen to allow wound healing to provide excessive amount of TON protein. This results in an abnormal scarring or fibrosis. This PRShe will solidify the heart, so it is inflexible. His symptoms include chest pain, some swelling of the abdomen, nausea and fatigue. This usually suggests a number of heart problems, with progressive heart failure. Other problems include accelerated heart rate or tachycardia and arrhythmia, irregular electrical activity of the heart due to myocyte loss.

myocardial heart state is particularly common in African subtropical areas. It is the most serious in countries such as Nigeria, where myocardial fibrosis is one of the main causes of adult heart diseases and culprit in about a quarter of heart disorder cases in children. Other affected African countries include Uganda and Mozambique. This is mainly prevailing in other substantially equatorial areas in the Indian subcontinent and South America.

There was no official cause for myocardial fibrosis. In addition, the disease is generally consideredis for irreversible. Patients tend to have an advanced stage when diagnosed because the symptoms are not particularly significant. This results in a short survival. Most patients with fibrosis of myocardial die in two or three years.

Despite limited knowledge and poor prognosis of myocard fibrosis, some progress has been made about the disease. For example, some scientists have proposed infection from diseases such as malaria, a high fiber diet and inflammation, as causes. It is also proposed that some proteins could reverse the process of hardening by reducing the rate of fibroblast development, which may eventually restore the flexibility of the heart.